For the quarter ending 2026-03-31, FEED made $653K in revenue. -$22,621K in net income. Net profit margin of -3464.17%.
| Income Statement | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Revenues | 653 | 638* | ||
| Cost of revenues | 708 | 600* | ||
| Gross profit (loss) | -55 | 38* | ||
| Research and development | 468 | 441* | ||
| Selling and marketing | 772 | 623* | ||
| General and administrative | 2,416 | 1,908* | ||
| Impairment of goodwill and long-lived assets | - | 2,788* | ||
| Total operating expenses | 3,656 | 5,760* | ||
| Loss from operations | -3,711 | -5,722* | ||
| Interest expense | 36 | - | ||
| Financial income (expense), net | -42 | 1,099* | ||
| Loss before taxes on income | -3,789 | -4,623* | ||
| Income tax expense | 33 | -77* | ||
| Net loss | -3,822 | -4,546* | ||
| Dividend on series x preferred stock | 623 | 425* | ||
| Dividend on series h preferred stock | 236 | 99* | ||
| Deemed dividend for down round feature on series h preferred stock | - | 100* | ||
| Deemed dividend for down round on series h preferred stock | 16,974 | - | ||
| Deemed contribution on repurchase of preferred series x | - | -22* | ||
| Deemed contribution on extinguishment of series x preferred stock | -131 | - | ||
| Deemed contribution on modification of preferred series x | - | -954* | ||
| Deemed dividend on modification of series h preferred stock | 1,097 | - | ||
| Net loss available to common stockholders | -22,621 | -4,194 | ||
| Basic EPS | -6.88 | -6.672 | ||
| Diluted EPS | -6.88 | -6.672 | ||
| Basic Average Shares | 3,289,049 | 628,534 | ||
| Diluted Average Shares | 3,289,049 | 628,534 | ||
ENvue Medical, Inc. (FEED)
ENvue Medical, Inc. (FEED)